Isolated functional tricuspid regurgitation: how to define patients at risk for event?

Author:

L'Official Guillaume1,Vely Mathilde1,Kosmala Wojciech2,Galli Elena1,Guerin Anne1,Chen Elisabeth1,Sportouch Catherine3,Dreyfus Julien4,Oger Emmanuel5,Donal Erwan1

Affiliation:

1. University of Rennes, CHU Rennes, Inserm, LTSI – UMR 1099 F‐35000 Rennes France

2. Institute of Heart Diseases Wroclaw Medical University Wroclaw Poland

3. Clinique Le Millenaire Montpellier France

4. Centre Cardiologique du Nord Saint Denis France

5. EA Reperes, CHU Rennes, University of Rennes Rennes France

Abstract

AbstractAimsFunctional tricuspid regurgitation (TR) is a turning point in cardiac diseases. Symptoms typically appear late. The optimal timing for proposing a valve repair remains a challenge. We sought to analyse the characteristics of right heart remodelling in patients with significant functional TR to identify the parameters that could be used in a simple prognostic model predicting clinical events.Methods and resultsWe designed a prospective observational French multicentre study including 160 patients with significant functional TR (effective regurgitant orifice area > 30 mm2) and left ventricular ejection fraction > 40%. Clinical, echocardiographic, and electrocardiogram data were collected at baseline and at the 1 and 2 year follow‐up. The primary outcome was all‐cause death or hospitalization for heart failure. At 2 years, 56 patients (35%) achieved the primary outcome. The subset with events showed more advanced right heart remodelling at baseline, but similar TR severity. Right atrial volume index (RAVI) and the tricuspid annular plane systolic excursion to systolic pulmonary arterial pressure (TAPSE/sPAP) ratio, reflecting right ventricular–pulmonary arterial coupling, were 73 mL/m2 and 0.40 vs. 64.7 mL/m2 and 0.50 in the event vs. event‐free groups, respectively (both P < 0.05). None among all the clinical and imaging parameters tested had a significant group × time interaction. The multivariable analysis leads to a model including TAPSE/sPAP ratio > 0.4 (odds ratio = 0.41, 95% confidence limit 0.2 to 0.82) and RAVI > 60 mL/m2 (odds ratio = 2.13, 95% confidence limit 0.96 to 4.75), providing a clinically valid prognostic evaluation.ConclusionsRAVI and TAPSE/sPAP are relevant for predicting the risk for event at 2 year follow‐up in patients with an isolated functional TR.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. Multicentric randomized evaluation of a tricuspid valve percutaneous repair system (clip for the tricuspid valve) in the treatment of severe secondary tricuspid regurgitation Tri. Fr Design paper;Donal E;Eur Heart J Cardiovasc Imaging,2021

2. PrazF MuraruD KreidelF LurzP HahnR DelgadoV SenniM vonBardelebenR NickenigG HausleiterJ MangieriA ZamoranoJ PrendergastB MaisanoF.Transcatheter treatment for tricuspid valve disease.EuroIntervention.https://eurointervention.pcronline.com/article/transcatheter‐treatment‐for‐tricuspid‐valve‐disease(Accessed 27 Nov 2021).

3. The tale of functional tricuspid regurgitation: when atrial fibrillation is the villain

4. Anatomy and Physiology of the Tricuspid Valve

5. Morphologic Types of Tricuspid Regurgitation

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3